EverSource Wealth Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-527
Closed -$22.4K 2692
2023
Q2
$22.2K Buy
527
+501
+1,927% +$20.3K ﹤0.01% 1117
2023
Q1
$926 Buy
26
+11
+73% +$399 ﹤0.01% 2130
2022
Q4
$550 Sell
15
-147
-91% -$5.81K ﹤0.01% 2189
2022
Q3
$8K Buy
162
+104
+179% +$6.72K ﹤0.01% 1220
2022
Q2
$4K Buy
+58
New +$4.24K ﹤0.01% 1366
2022
Q1
Sell
-16
Closed -$2K 1896
2021
Q4
$2K Buy
+16
New +$1.54K ﹤0.01% 1657

Other funds holding SYNH

EverSource Wealth Advisors's SYNH Position: Q3 2023 in Review

EverSource Wealth Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 527 shares — an estimated $22.4K sold.

EverSource Wealth Advisors first reported a position in SYNH in Q4 2021 and held it in 6 quarters. The position peaked at $22.2K in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • EverSource Wealth Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • EverSource Wealth Advisors sold 527 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $22.4K.
  • EverSource Wealth Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
  • EverSource Wealth Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $22.2K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on EverSource Wealth Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.